|
gptkbp:instance_of
|
gptkb:fragrance
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:Adapt_Pharma
gptkb:naloxone
|
|
gptkbp:appointed_by
|
bystanders
non-medical personnel
|
|
gptkbp:approves
|
gptkb:2015
gptkb:FDA
|
|
gptkbp:availability
|
widely available in pharmacies
|
|
gptkbp:average_temperature
|
room temperature
|
|
gptkbp:brand
|
gptkb:Narcan
|
|
gptkbp:can_be
|
respiratory depression
|
|
gptkbp:can_be_used_with
|
other medications
|
|
gptkbp:clinical_trial
|
conducted for efficacy
|
|
gptkbp:community
|
programs exist
|
|
gptkbp:countermeasures
|
effects of opioids
|
|
gptkbp:duration
|
30 to 90 minutes
|
|
gptkbp:economic_impact
|
reduces opioid overdose deaths
|
|
gptkbp:emergency_services
|
gptkb:battle
|
|
gptkbp:formulation
|
nasal spray and injectable
|
|
gptkbp:healthcare
|
gptkb:significant
gptkb:battle
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Narcan
|
|
gptkbp:ingredients
|
gptkb:naloxone
|
|
gptkbp:is
|
a substitute for medical care
|
|
gptkbp:is_available_in
|
gptkb:various_countries
|
|
gptkbp:is_available_on
|
generic drug
|
|
gptkbp:is_effective_against
|
non-opioid overdoses
treating opioid overdose
|
|
gptkbp:is_fed_by
|
pharmacists
|
|
gptkbp:is_part_of
|
opioid overdose response kits
|
|
gptkbp:is_used_by
|
first responders
|
|
gptkbp:is_used_for
|
opioid overdose
|
|
gptkbp:legal_issue
|
prescription-only in some regions
|
|
gptkbp:manager
|
intranasal
|
|
gptkbp:manufacturer
|
gptkb:Adapt_Pharma
|
|
gptkbp:name
|
gptkb:naloxone
|
|
gptkbp:packaging
|
single-dose spray
|
|
gptkbp:part_of
|
harm reduction strategies
|
|
gptkbp:price
|
varies by location
|
|
gptkbp:public_awareness
|
conducted to promote use
|
|
gptkbp:receives_funding_from
|
covered by many insurance plans
|
|
gptkbp:requires
|
available online
medical attention after use
|
|
gptkbp:risk_factor
|
none when used as directed
|
|
gptkbp:side_effect
|
withdrawal symptoms
|
|
gptkbp:suitable_for
|
gptkb:CDC
|
|
gptkbp:targets
|
opioid receptors
|
|
gptkbp:training
|
available for community members
offered by organizations
available for healthcare providers
minimal training for use
|
|
gptkbp:type
|
gptkb:Naloxone
|
|
gptkbp:used_in
|
emergency situations
|
|
gptkbp:venomous
|
gptkb:theorem
|